No Benefit from Chronic Lithium Dosing in a Sibling-Matched, Gender Balanced, Investigator-Blinded Trial Using a Standard Mouse Model of Familial ALS

Open Access

Peer-reviewed

Research Article

Alan Gill ,

* E-mail: agill@als.net

Affiliation ALS Therapy Development Institute, Cambridge, Massachusetts, United States of America
⨯
Joshua Kidd,

Affiliation ALS Therapy Development Institute, Cambridge, Massachusetts, United States of America
⨯
Fernando Vieira,

Affiliation ALS Therapy Development Institute, Cambridge, Massachusetts, United States of America
⨯
Kenneth Thompson,

Affiliation ALS Therapy Development Institute, Cambridge, Massachusetts, United States of America
⨯
Steven Perrin

Affiliation ALS Therapy Development Institute, Cambridge, Massachusetts, United States of America
⨯

Reader Comments (0)

Lithium
Is the Subject Area "Lithium" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Animal models of disease
Is the Subject Area "Animal models of disease" applicable to this article?

Thanks for your feedback.
Carbonates
Is the Subject Area "Carbonates" applicable to this article?

Thanks for your feedback.
Neurological drug therapy
Is the Subject Area "Neurological drug therapy" applicable to this article?

Thanks for your feedback.
Amyotrophic lateral sclerosis
Is the Subject Area "Amyotrophic lateral sclerosis" applicable to this article?

Thanks for your feedback.
Animal models
Is the Subject Area "Animal models" applicable to this article?

Thanks for your feedback.
Isotonic
Is the Subject Area "Isotonic" applicable to this article?

Thanks for your feedback.